Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?
暂无分享，去创建一个
Rajiv Kumar | A. Mahajan | A. Bhattacharjee | K. Prabhash | V. Noronha | V. Patil | A. Joshi | N. Pande | A. Chandrasekharan | A. Ramaswamy | A. Karpe | V. Talreja | N. Purandare | A. Chougule | A. Janu | S. Goud | S. More | A. Goel